Dipòsit Digital de la Universitat de Barcelonametadata only
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy
càncer de ronyó, inhibidors enzimàtics, renal cancer, enzyme inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.